![Karl Kelley](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Karl Kelley
Directeur Technique/Scientifique/R&D chez RAIsonance, Inc.
Postes actifs de Karl Kelley
Sociétés | Poste | Début | Fin |
---|---|---|---|
RAIsonance, Inc.
![]() RAIsonance, Inc. Information Technology ServicesTechnology Services RAIsonance, Inc. is a family of companies based in the Denver Tech Center that specializes in artificial intelligence/machine learning-based healthcare solutions. The American company operates wellness products such as MyAdvocate and Biometric SoundPass for consumers, and the workforce wellness solution FCV Sentinel for the enterprise. Additionally, RAIsonance is developing diagnostic solutions for COVID-19, influenza, tuberculosis, and RSV. Originally funded with a grant from the National Science Foundation, RAIsonance has developed breakthrough technology innovations that use signal data signature recognition as a biomarker for human medical diagnostics and to support ground-breaking safety applications. The company was founded in 2020 by Catherine M. Kolding, who has been the CEO since then. | Directeur/Membre du Conseil | - | - |
Directeur Technique/Scientifique/R&D | - | - |
Historique de carrière de Karl Kelley
Statistiques
Internationale
Etats-Unis | 2 |
Opérationnelle
Director/Board Member | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Sectorielle
Technology Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 1 |
---|---|
RAIsonance, Inc.
![]() RAIsonance, Inc. Information Technology ServicesTechnology Services RAIsonance, Inc. is a family of companies based in the Denver Tech Center that specializes in artificial intelligence/machine learning-based healthcare solutions. The American company operates wellness products such as MyAdvocate and Biometric SoundPass for consumers, and the workforce wellness solution FCV Sentinel for the enterprise. Additionally, RAIsonance is developing diagnostic solutions for COVID-19, influenza, tuberculosis, and RSV. Originally funded with a grant from the National Science Foundation, RAIsonance has developed breakthrough technology innovations that use signal data signature recognition as a biomarker for human medical diagnostics and to support ground-breaking safety applications. The company was founded in 2020 by Catherine M. Kolding, who has been the CEO since then. | Technology Services |
- Bourse
- Insiders
- Karl Kelley
- Expérience